What is the NOAEL for Amiloxate?
Amiloxate has 6 NOAEL studies in the database. The lowest reported value is 7.05 mg/m3 via inhalation in Human. Source: ToxValDB_GESTIS_DNEL.
Also known as: 3-10-00-00850, BRN 3132627, EINECS 275-702-5, 3-(4-Methoxyphenyl)-2-propenoic acid, 3-methylbutyl ester, 3-Methylbutyl 3-(4-methoxyphenyl)-2-propenoate (+2 more)
CAS 71617-10-2
Amiloxate (CAS 71617-10-2) is a chemical substance. Key regulatory status: REACH registered, 2 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
View cosmetic safety profile for Amiloxate (Isoamyl p-Methoxycinnamate) →
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Canada; pharmaceutical | DrugBank | DrugBank |
| Europe; Personal care | European Commission | CosIng |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| =7.05 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 376KTP06K8 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 376KTP06K8 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 376KTP06K8 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 376KTP06K8 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| =9600 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
Showing 6 of 6 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Isopentyl p-methoxycinnamate | 275-702-5 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Amiloxate has 6 NOAEL studies in the database. The lowest reported value is 7.05 mg/m3 via inhalation in Human. Source: ToxValDB_GESTIS_DNEL.
Amiloxate appears on 2 regulatory/inventory lists including Canada; pharmaceutical, Europe; Personal care. Source: EPA CPDat.
Yes, Amiloxate is also indexed as a cosmetic ingredient under the name Amiloxate (Isoamyl p-Methoxycinnamate). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Amiloxate also appears in cosmetics, pharmaceutical databases.